This ACE Clinical Guidance (ACG) covers clinical assessment, pharmacological treatment, and non-pharmacological strategies for managing asthma over the long term, with a focus on inhaled corticosteroid as the mainstay. The accompanying Appendix provides a list of preventer medications registered for asthma in Singapore.
Download the PDF below to access the ACG.
Registered doctors and pharmacists may claim 1 Continuing Medical Education (CME)/Continuing Professional Education (CPE) point under category 3A for reading each ACG.
Asthma Management (Nov 2020)
Asthma Management Appendix (Oct 2020)
Asthma Management References (Oct 2020)
|1.||Regularly assess asthma symptoms and risk of poor asthma outcomes, including factors that can influence these.|
|2.||Consider using a validated questionnaire to assess asthma symptoms.|
|3.||Assess factors influencing asthma symptoms or risk of poor asthma outcomes. These can be remembered with the acronym BREATHE.|
|4.||Use inhaled corticosteroid as the mainstay of long-term asthma management.|
|5.||For patients aged 6 years and older, do not use short-acting beta2agonist alone (without a preventer) to treat asthma long term.|
|6.||Use a stepwise approach when selecting or adjusting preventer treatment for asthma (see Figure 2 on page 6).|
|7.||Educate all patients with asthma or their caregivers on how to self-manage.|
|8.||Regularly follow up all patients with asthma.|
|9.||Referral to a specialist could be made at any point.|
Click here to give us feedback on this ACG.
Other related resources